11th Annual Hematology and Medical Oncology Board Review
This MSK review presents historical 2023 teaching material for hematology and medical oncology study. It does not include publisher account registration or CME credit.
This on-demand material was recorded over 3.5 days and presents a 2023 review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty from Memorial Sloan Kettering focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.
Original Course Learning Objectives
- Review diagnosis, staging and treatment principles across solid tumors and hematologic malignancies.
- Examine the treatment developments discussed in the original course.
- Support study for hematology and medical oncology board examinations.
For clinical decisions, check current guidelines; historical course material may not reflect subsequent changes.



